Katherine Keller

Katherine Keller is an executive director leading the US Farxiga Franchise at AstraZeneca, a position Katherine has held since 2023. With over 23 years of experience in the pharmaceutical field, Katherine has demonstrated expertise across various domains, including Managed Markets and Marketing, while managing P&L responsibilities. Previously, Keller held multiple roles at AstraZeneca, notably as Senior Director of Market Access for Respiratory Inhaled & Biologics and Executive Director of Diabetes Sales, where Katherine led significant teams and initiatives. Katherine earned a Bachelor's degree in Biology/Writing from Loyola College in Maryland and has received recognition for her leadership, including multiple Presidents Awards.